Companies / Allogene Therapeutics, Inc. / Activity
Activity — Allogene Therapeutics, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | David D. Chang, M.D., Ph.D. CEO | Sell | Common Stock | $118.0K | -48K -0.92% | 5,150,599 1.49% of shares | medium |
| Feb 2, 2026 | David D. Chang, M.D., Ph.D. CEO | Sell | Common Stock | $171.5K | -95K -1.80% | 5,185,862 1.50% of shares | medium |
| Feb 2, 2026 | David D. Chang, M.D., Ph.D. CEO | Grant | Restricted Stock Unit | — | +393K | 392,586 0.11% of shares | low |
| Feb 2, 2026 | David D. Chang, M.D., Ph.D. CEO | Grant | Stock Option (Right to buy) | — | +1.4M | 1,387,931 0.40% of shares | low |